Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden flag Sweden · Delayed Price · Currency is SEK
14.40
-0.10 (-0.69%)
At close: Mar 9, 2026

STO:ANNX Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-36.89-50.25-44.05-40.73-52.14
Upgrade
Depreciation & Amortization
-0.190.190.190.19
Upgrade
Other Operating Activities
0.1900-5.19
Upgrade
Change in Accounts Payable
0.01-1.371-0.180.61
Upgrade
Change in Other Net Operating Assets
-0.241.2-0.54-0.451.13
Upgrade
Operating Cash Flow
-36.93-50.23-43.4-41.17-45.02
Upgrade
Capital Expenditures
-0.13----
Upgrade
Investment in Securities
--0.1-0.26-
Upgrade
Investing Cash Flow
-0.13-0.1-0.26-
Upgrade
Long-Term Debt Issued
-510-20
Upgrade
Net Debt Issued (Repaid)
-510-20
Upgrade
Issuance of Common Stock
49.9740.0626.523.1166.66
Upgrade
Other Financing Activities
-1.860.1-2.9-0.05-10.29
Upgrade
Financing Cash Flow
48.1145.1533.6123.0676.37
Upgrade
Miscellaneous Cash Flow Adjustments
--0-0--
Upgrade
Net Cash Flow
11.06-5.08-9.7-18.3731.35
Upgrade
Free Cash Flow
-37.05-50.23-43.4-41.17-45.02
Upgrade
Free Cash Flow Per Share
-5.60-11.11-25.97-28.14-54.88
Upgrade
Cash Interest Paid
-0.050--
Upgrade
Levered Free Cash Flow
-23.05-31.48-26.87-26.05-28.92
Upgrade
Unlevered Free Cash Flow
-23.05-31.48-26.87-26.05-27.76
Upgrade
Change in Working Capital
-0.23-0.170.46-0.631.74
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.